Loading clinical trials...
Loading clinical trials...
A Pilot Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
Conditions
Interventions
Intranasal Oxytocin
Locations
1
United States
Massachusetts General Hospital
Cambridge, Massachusetts, United States
Start Date
October 9, 2017
Primary Completion Date
January 9, 2019
Completion Date
January 9, 2019
Last Updated
July 1, 2024
NCT06066983
NCT07439276
NCT06158581
NCT04631042
NCT07421830
NCT05066178
Lead Sponsor
Massachusetts General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions